Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250274 · ClinicalTrials.gov registry record · Phase 4
Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents
A Phase 4 study, sponsored by Marshfield Clinic Research Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 131
- Enrollment target
NCT02250274 is a Phase 4 study that has completed, run by Marshfield Clinic Research Foundation. The registered enrollment target is 131 participants.
The verdict
NCT02250274, a Phase 4 study, has completed, sponsored by Marshfield Clinic Research Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the serologic and cell-mediated immune response to licensed live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children 5-17 years old. The effects of prior infection and or prior season vaccination will be examined. Children will be followed during the influenza season to identify laboratory-confirmed influenza (i.e. vaccine failure).
Interventions
- BIOLOGICAL LAIV
- BIOLOGICAL IIV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02250274
The ClinicalTrials.gov registry entry for NCT02250274 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marshfield Clinic Research Foundation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LAIV is the first listed.
NCT02250274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02250274 about?
NCT02250274 is a clinical study titled "Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents". The purpose of this study is to assess the serologic and cell-mediated immune response to licensed live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children 5-17 years old. The effects of prior infection and or prior season vaccination will be examined. Children wi...
What is the current status of trial NCT02250274?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2014-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02250274?
The interventions under investigation include: LAIV (BIOLOGICAL), IIV (BIOLOGICAL).
Who is sponsoring clinical trial NCT02250274?
This trial is sponsored by Marshfield Clinic Research Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.